UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Novel translational model of resolving inflammation triggered by UV-killed E. coli

Motwani, MP; Flint, JD; De Maeyer, RP; Fullerton, JN; Smith, AM; Marks, DJ; Gilroy, DW; (2016) Novel translational model of resolving inflammation triggered by UV-killed E. coli. The Journal of Pathology: Clinical Research , 2 (3) pp. 154-165. 10.1002/cjp2.43. Green open access

[thumbnail of Gilroy_Motwani_et_al-2016-The_Journal_of_Pathology-_Clinical_Research.pdf]
Preview
Text
Gilroy_Motwani_et_al-2016-The_Journal_of_Pathology-_Clinical_Research.pdf

Download (924kB) | Preview

Abstract

Whilst numerous studies investigating the aetiology of inflammatory diseases have been performed in rodents, the applicability of these data to human pathophysiology is frequently debated. Regardless of the strengths and weaknesses of rodent models in biomedical research, there is a need to develop models of experimental inflammation in humans. Here, we describe a self-resolving acute inflammatory response triggered by the intradermal injection of UV-killed Escherichia coli into the forearm of healthy volunteers. Cells and exudates were harvested from onset to resolution by applying negative pressure over the inflamed site. Onset was characterized by high blood flow, neutrophilia and peak levels of pro-inflammatory cytokines, whilst resolution showed a decline in blood blow, reduction in neutrophils, increase in monocytes/macrophages and waning of classic pro-inflammatory cytokine levels. An anti-inflammatory effect, defined as suppression of onset phase events, was demonstrated by administering naproxen, a conventional non-steroidal anti-inflammatory drug. In summary, this model of resolving acute inflammation is minimally invasive, highly tractable and allows simultaneous investigation of the vascular response, cellular trafficking and chemical mediator profile of onset and resolution phases of acute inflammation in humans. It can serve as a translational platform to provide mechanistic insights and to test the clinical efficacy of novel anti-inflammatory and pro-resolving drugs, and also as a tool in patients to explore inherent defects in resolution pathways.

Type: Article
Title: Novel translational model of resolving inflammation triggered by UV-killed E. coli
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/cjp2.43
Publisher version: http://dx.doi.org/10.1002/cjp2.43
Language: English
Additional information: Copyright © 2016 The Authors The Journal of Pathology: Clinical Research published by The Pathological Society of Great Britain and Ireland and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: human in vivo model, macrophage, neutrophil, resolution of inflammation, translational research
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Experimental and Translational Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Eastman Dental Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > UCL Medical School
URI: https://discovery.ucl.ac.uk/id/eprint/1494754
Downloads since deposit
110Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item